My Penny Stock Watch-List for 4.11.2019 ---> 💵💵💯 $EDXC $AGEEF $CFRX $PRTO
When to use a Watch-list: An investor, for example, may be interested in purchasing stocks in a particular sector. But if that sector is generally overvalued, it may offer few stocks that are attractively priced. An investor could create a list of all the stocks in that sector that would track various valuation measures, including ratios such as trailing price-to-earnings, price-to-sales, price-to-book, among others. When a company on the list met a specified valuation criterion, such as a PE ratio less than 15, he or she would then know that this stock was a possible candidate for investment. Many investment-oriented websites allow visitors to create watch-lists online.
Ticker Symbols: $EDXC $AGEEF $CFRX $PRTO
CFRX - ContraFect Corp. is a clinical stage biotechnology company , which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
EDXC - Endexx Corp. is a diversified holding company, which engages in the plant-based nutraceuticals and emerging technologies. It operates through the following divisions: M3Hub Technology, CBD Unlimited, and Project Canopy. The company was founded in September 1997 and is headquartered in Cave Creek, AZ.
AGEEF - Halo Labs, Inc. is a cannabis extraction company, which engages in the development and manufacture of cannabis oils and concentrates. The company was founded in 2016 and is headquartered in Toronto, Canada.
PRTO - Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.
Post a Comment